Abstract
5-Hydroxytryptamine (5-HT) is mitogenic for vascular smooth muscle cells, an effect that may result from 5-HT2 receptor activation. After arterial balloon injury, platelet-derived products including 5-HT are delivered to the denuded vessel wall via platelet adhesion/aggregation and degranulation. To assess the role of 5-HT2 receptors in neointima formation, the selective 5-HT2 receptor antagonist LY215840 was infused continuously in rats with osmotic minipumps from 2 days before until 2 weeks after balloon injury to the left common carotid artery, at which time effects upon intimal thickening were examined. Chronic i.v. infusion of LY215840 (25 micrograms/kg/hr) produced a significant, rightward shift (approximately 500-fold) in the 5-HT pressor-response curve in pithed rats determined at 1 hr, 4 days or 16 days after initiation of infusion. Under these conditions, LY215840 had no significant effect upon cross-sectional intimal area determined 2 weeks postballoon injury (0.118 +/- 0.010 vs. 0.114 +/- 0.017 mm2 for vehicle- and LY215840-treated groups, respectively). Furthermore, the cellular density of neointima from LY215840-treated rats was unchanged relative to that of the vehicle group. As a positive control, heparin infusion produced dose-dependent reductions in intimal thickening in this model. At the infusion rate of 0.22 mg/kg/hr, heparin reduced intimal area from a control value of 0.114 +/- 0.015 to 0.025 +/- 0.007 mm2 (P < .05). Thus, extensive blockade of vascular 5-HT2 receptors does not inhibit neointima formation in this model of vascular balloon injury.
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|